An accredited Developing
Stage business incubator
uk inspire Send this page | Bookmark | Print |

Business incubator for biotech and medtech startups

 

Secretary of State visits Cardiff Medicentre

Secretary of State visits Cardiff Medicentre

 


 

Staff and tenants at Cardiff Medicentre were delighted to be paid a visit by the Secretary of State for Wales, David Jones, on his latest trip to Cardiff.

 

Accompanied by Nick Baird, Chief Executive of UKTI, Mr Jones visited WIMAT and MedaPhor Ltd at their state-of-the art laboratories in the heart of Cardiff Medicentre.

 

Mr Robert Jackson Innovation Manager at Cardiff Medicentre said; "There was a great deal of interest in what we're doing here at Cardiff Medicentre, and recognition of our success in nurturing some fantastic businesses. The Secretary of State was particularly interested in how our tenants are creating opportunities here in Wales, and promoting our country overseas."

 

The party also listened with interest to a presentation by Dr Jonny Ryves on his new start-up company Cupid Peptide Limited.

 

Dr Ryves said: "We greatly enjoyed the opportunity to talk to the Rt. Honorable David Jones MP and the Chief Executive of the UKTI, Nick Baird and we were very encouraged by their positive response to Cupid Peptide technology."

Stuart Gall CEO of Medaphor Ltd commented:
“We were delighted that the Rt Honorable David Jones could see how well our company is doing. A Cardiff University start-up, we are now selling our advanced simulators in 11 countries around the world and are poised to rapidly expand over the coming months.

“MedaPhor is an excellent example of how private and public money can work together to turn university research into a thriving business, exporting around the world. The support of the Welsh Government,

Fusion IP and Finance Wales has been vital in enabling the company to turn the founder, Prof Amso’s, brilliant concept into Welsh jobs and export revenue"

 

 

 

Published on Wed, 16th Oct 2013

 
tenants
how to apply
directions

Follow us

  • RSS Feed